Covid-19 Diagnostics Market Analysis & Opportunities

Covid-19 Diagnostics Market Outlook and Findings

[280 Pages Report] The Covid-19 diagnostics market players look to develop highly sensitive and specific testing kits
RT-PCR remains the most widely used diagnostic test globally
Leading players boosting production by launching automated COVID-19 testing systems
Springing up of local players to combat Covid-19 providing a competitive edge to the market

Don't pay for what you don't need

Customize your report by selecting specific countries or regions and save 30%!

Covid-19: A Snapshot

As of now, the world is battling Covid-19. The name “Covid-19” says “Corona Virus Disease -2019” as the first traces were found in human body in 2019.

The term “Corona Virus” is coined regarding the family of viruses that get transmitted between humans and animals. As such, they are also called “zoonotic viruses”.

By the end of Mar 2020, the WHO confirmed that Covid-19 outbreak has spread to 213 countries across 6 continents.

The common symptoms observed are dry cough, fatigue, fever, sore throat, shortness of breath, body pain/ache, and even diarrhea in a few cases. At times, runny nose and nausea are also observed.

Till recently, this infection was reported to spread from person to person through saliva or nasal discharge, especially on the infected person sneezing or coughing. However, of late, WHO issued guidelines for airborne transmission as well. The time between a person getting exposed to Covid-19 and onset of symptoms is usually 12-14 days.

Key Market Trends

RT PCR (Reverse Trascriptase PCR) remains the preferred mode of treatment for coronavirus testing. This technique is advantageous such that primers used can be produced with utmost speed.

As such, multiplex RT PCR is the most preferred diagnostic test with regards to Covid-19. Many molecular diagnostics companies are focusing on developing affordable RT PCR tests.

Along the above-mentioned lines, efforts are being taken by certain players to cater to the increasing number of Covid-19 affected patients. They are likely to substantiate the Covid-diagnostics market in the forecast period (2020-2030).

For instance –

In Jul 2020, Avacta announced beginning of clinical validation of high throughput Covid-19 laboratory test (Adeptrix Covid-19 diagnostic test) by collaborating with CONDOR program by the government of UK
In Jul 2020, BATM launched 3 novel diagnostic kits, namely – Covid-19 serologic test, Covid-19 antigen test, and new molecular diagnostics test for advancing Covid-19’s diagnosis
In July 2020, Mylab launched “Compact XL”, a machine for automating all the manual processes of molecular diagnostic tests, inclusive of Covid-19’s RT-PCR tests
In Jul 2020, The National Institute of Health selected the rapid Covid-19 test under the Rapid Acceleration of Diagnostics Tech (RADx Tech) program. Researchers at MIT, along with 3M have started with an accelerated research to check if a simple device could produce accurate results and its feasibility regarding mass production
In Jul 2020, Quest Diagnostics received authorization from the US FDA regarding laboratory technique to be employed in Covid-19 diagnostic testing
In June 2020, T2 Biosystems, Inc. announced that it had finished with validation of Covid-19 molecular diagnostic test – the “T2SARS-CoV-2 Panel” under license agreement with Hackensack Meridian Health’s Center of Discovery and Innovation. Distribution at the commercial level has been permitted after having met requirements for an EUA (Emergency Use Authorization) request to the US FDA
In Jun 2020, Mobidiag received CE-IVD markings relating to the two tests enabling reliable and rapid detection of Covid-19. They are – Amplidiag Covid-19 for catering to large laboratories for batch volume tests and Novodiag Covid-19 for on-demand, single tests

Talk to Analyst

Find your sweet spots for generating winning opportunities in this market.

Research and Offbeat Discoveries to Drive the Market

Apart from the market players, educational and research institutes are putting their best foot forward to develop safer and quicker coronavirus diagnostic test kits.

For instance –

In Jul 2020, AdvaMed announced creation of an exhaustive national Covid-19 diagnostic supply registry for lending a helping hand to federal and state pandemic responses.
In Jul 2020, The Journal of the American Osteopathic Association published a research paper that stated that obtaining eosinophil count also helps in detection of Covid-19. It also presented that out of Covid-19 patients, 60% did have zero eosinophils at presentation. The once not affected had not more than 16%.
India-based IIT Delhi, in Jul 2020, launched “Corosure”, the Covid-19 test kit at a base price of US $5 only.
In Jul 2020, SRL Diagnostics, in collaboration with Fortis Hospital, decided to launch antigen test facility to diagnose Covid-19 in Karnataka, India.

Players to fill the Void for asymptomatic Patients

Recently, several people who had shown no symptoms of Covid-19 have been reported to have contracted Covid-19. This has actually put the healthcare personnel in a fix, as there is no way out other than mass testing.

To enable this testing at a large scale, Covid-19 testing kits also need to be available in large numbers. For instance – Roche’s testing head mentioned that demand for equipment for processing Covid-19 tests has increased to the levels it would normally see over 4 to 5 years.

On these grounds, the company is planning to introduce novel antibody tests by the end of 2020 to widen its offering pertaining to the same.

Moreover, local players across the globe are trying their best to table Covid-19 test kits, so that detection gets speeded up and so do the medications. For instance – In Apr 2020, FastSense Diagnostics, an India-based start-up, developed rapid diagnostic kits to screen Covid-19.

Similarly, South Korea-based SD Biosensor, in Apr 2020, obtained the license to produce Covid-19 test kits in India. Also, Voxtur Bio, around the same time, started manufacturing rapid test kits to address Covid-19.

Covid-19 Diagnostics Market: Regional Analysis

Covid-19 Diagnostics Market

The Covid-19 pandemic has taken the entire world on a ride. As of now, the US, Russia, Italy, Spain, Brazil, India, Australia are amongst the worst affected countries. As such, North America, Europe, Latin America, Oceania, Asia-Pacific – all the continents are battling Covid-19. Right now, there are 14,971,036 confirmed cases, inclusive of 618,017 deaths, as reported by the WHO.

Americas is top-seeded with 7,948,513, Europe stands second with 3,124,701, and South-East Asia with 1,571,317 confirmed cases. So, Americas are requiring the highest number of Covid-19 test kits. The status quo is expected to remain the same in the subsequent quarters as it will definitely take time for Covid-19 to reach the “below par” mark.

Also, Switzerland and Czech Republic have increasing testing capacity on their part in the last few months. As far as Asia Pacific is concerned, profitable partnership initiatives amongst India, South Korea, Japan regarding penetration of Covid-19 diagnostic products are expected to bolster the market

Major Players in the Covid-19 Diagnostics Market

The key players are into accelerating production as well as supply of Covid-10 diagnostic test kits for keeping pace with requirement for disease containment. For example – Roche, in Mar 2020, did initiate shipment of Cobas SARS-CoV-2 test kits’ first allotment.

Around 400,000 test kits were shipped all across the US hospitals and reference laboratories. Likewise, it started shipping additional 400,000 additional test kits every week.

Likewise, the players are working on collaborative approach to cope with Covid-19 crisis and also expand business. For instance, Quest Diagnostics, in May 2020, collaborated with Ortho Clinical Diagnostics with the objective of expanding Covid-19 testing across 20+ labs all through the US. Ortho’s VITROS Immunodiagnostic products Anti-SARS-CoV-2 IgG test for speeding up Covid-19 testing in the patients.

The other major players include:

Veredus Laboratories
Thermo Fisher Scientific, Inc.
Quidel Corporation
Perkin Elmer, Inc.
Neuberg Diagnostics
Mylab Discovery Solutions Pvt Ltd.
Luminex Corporation
Laboratory Corporation of America Holdings
Hologic Inc.
Danaher
Cepheid
bioMérieux SA
Altona Diagnostics GmbH
ALDATU BIOSCIENCES
ADT Biotech Sdn Bhd
Abbott
1drop Inc.

Covid-19 Diagnostics market: The Way Forward

The Covid-19 diagnostics market is expected to go strong in the upcoming period. Even when a vaccine is eventually developed, testing will still be around, as inoculating entire population will take time.

The market players are already on to the expansion spree in terms of production of diagnostic kits. However, they need to devise ways to mellow down on the costs, which is one of the most competitive factors for them at the global level. The local players are already giving them a tough fight in this regard.

Key Segment

Product Type

Instruments
Test Kits
Reagents and Consumables

Sample Type

Oropharyngeal & Nasopharyngeal Swabs
Blood
Urine
Others

Technology

PCR
ELISA
POC

Region

North America
Latin America
Europe
East Asia
South Asia
Oceania
Middle East and Africa

Frequently Asked Questions

What is the Growth Outlook for Covid-19 Diagnostics Market?

The covid-19 diagnostics market is likely to secure a CAGR of 7.7% through 2032.

By 2032, how much can the Covid-19 Diagnostics Market Grow?

The covid-19 diagnostics market size is estimated to cross US$ 204.51 Bn by 2032.

What is the Current Valuation of the Covid-19 Diagnostics Market?

The covid-19 diagnostics market is likely to record a value of US$ 97.4 Bn in 2022.

Which Region is likely to Lead the Covid-19 Diagnostics Market?

Europe is likely to lead the covid-19 diagnostics market.

Table of Content

1. Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

3. Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

4. Key Success Factors

4.1. Technology Adoption / Usage Analysis

4.2. Key Product Features and their USPs

4.3. Key Promotional Strategies, By Manufacturers

4.4. Regulations, By Region

5. Global Market (Volume in Units) Analysis 2015-2019 and Forecast, 2020-2030

5.1. Historical Market Volume (in Units) Analysis, 2015-2019

5.2. Current and Future Market Volume (in Units) Projections, 2020-2030

6. Global Market - Pricing Analysis

6.1. Average Pricing Analysis By Region

6.2. Pricing Break-up

6.2.1. Manufacturer Level Pricing

6.2.2. Distributor Level Pricing

6.3. Global Average Pricing Analysis Benchmark

7. Global Market Demand (Size in US$ Mn) Analysis 2015-2019 and Forecast, 2020-2030

7.1. Historical Market Value (US$ Mn) Analysis, 2015-2019

7.2. Current and Future Market Value (US$ Mn) Projections, 2020-2030

7.2.1. Y-o-Y Growth Trend Analysis

7.2.2. Absolute $ Opportunity Analysis

8. Market Background

8.1. Macro-Economic Factors

8.1.1. Global GDP Growth Outlook

8.1.2. Per Capita Healthcare Expenditure Outlook

8.2. Forecast Factors - Relevance & Impact

8.2.1. Increase in R&D Funding and Grants

8.2.2. Increase in Number of Corona Virus Disease Cases

8.2.3. Diagnosis Seeking Rate

8.2.4. COVID-19 Disease Mortality Rate

8.2.5. Industry Consolidation to Increase Capacity

8.2.6. Increase in Manufacturing Activity

8.3. Market Dynamics

8.3.1. Drivers

8.3.2. Restraints

8.3.3. Opportunity Analysis

8.4. COVID19 Crisis Analysis

8.4.1. Current COVID19 Statistics and Probable Future Impact

8.4.2. Current GDP Projection and Probable Impact

8.4.3. Current Economic Projection as compared to 2008 Economic analysis

8.4.4. COVID19 and Impact Analysis

8.4.4.1. Revenue By Product Type

8.4.4.2. Revenue By Sample Type

8.4.4.3. Revenue By Technology

8.4.4.4. Revenue By End User

8.4.4.5. Revenue By Country

8.4.5. 2020 Market Scenario

8.4.6. Quarter by Quarter Forecast

8.4.7. Projected recovery Quarter

8.4.8. Recovery Scenario – Short term, Midterm and Long Term Impact

9. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Product Type

9.1. Introduction / Key Findings

9.2. Historical Market Size (US$ Mn) & Volume Analysis By Product Type, 2015-2019

9.3. Current and Future Market Size (US$ Mn) & Volume Analysis and Forecast By Product Type, 2020-2030

9.3.1. Instruments

9.3.2. Test Kits

9.3.2.1. Rapid Test Kits

9.3.2.2. Assay Based Test Kits

9.3.3. Reagents and Consumables

9.4. Market Attractiveness Analysis By Product Type

10. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Sample Type

10.1. Introduction / Key Findings

10.2. Historical Market Size (US$ Mn) By Sample Type, 2015-2019

10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Sample Type, 2020-2030

10.3.1. Oropharyngeal & Nasopharyngeal Swabs

10.3.2. Blood

10.3.3. Urine

10.3.4. Others

10.4. Market Attractiveness Analysis By Sample Type

11. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Technology

11.1. Introduction / Key Findings

11.2. Historical Market Size (US$ Mn) Analysis By Technology, 2015-2019

11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Technology, 2020-2030

11.3.1. PCR

11.3.2. ELISA

11.3.3. POC

11.4. Market Attractiveness Analysis By Technology

12. Global Market Analysis 2015-2019 and Forecast 2020-2030, by End User

12.1. Introduction / Key Findings

12.2. Historical Market Size (US$ Mn) Analysis By End User, 2015-2019

12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2020-2030

12.3.1. Hospitals

12.3.2. Speciality Clinics

12.3.3. Diagnostic Centers

12.3.4. Pathology Laboratories

12.3.5. Research Institutes

12.4. Market Attractiveness Analysis By End User

13. Global Market Analysis 2015-2019 and Forecast 2020-2030, by Region

13.1. Introduction

13.2. Historical Market Size (US$ Mn) & Volume Analysis By Region, 2015 - 2019

13.3. Current Market Size (US$ Mn) & Volume Analysis and Forecast By Region, 2020 - 2030

13.3.1. North America

13.3.2. Latin America

13.3.3. Europe

13.3.4. East Asia

13.3.5. South Asia

13.3.6. Oceania

13.3.7. Middle East and Africa (MEA)

13.4. Market Attractiveness Analysis By Region

14. North America Market Analysis 2015-2019 and Forecast 2020-2030

14.1. Introduction

14.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

14.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

14.3.1. By Country

14.3.1.1. U.S.

14.3.1.2. Canada

14.3.2. By Product Type

14.3.3. By Sample Type

14.3.4. By Technology

14.3.5. By End User

14.4. Market Attractiveness Analysis

14.5. Key Market Participants - Intensity Mapping

14.6. Drivers and Restraints - Impact Analysis

15. Latin America Market Analysis 2015-2019 and Forecast 2020-2030

15.1. Introduction

15.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

15.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

15.3.1. By Country

15.3.1.1. Brazil

15.3.1.2. Mexico

15.3.1.3. Argentina

15.3.1.4. Rest of Latin America

15.3.2. By Product Type

15.3.3. By Sample Type

15.3.4. By Technology

15.3.5. By End User

15.4. Market Attractiveness Analysis

15.5. Key Market Participants - Intensity Mapping

15.6. Drivers and Restraints - Impact Analysis

16. Europe Market Analysis 2015-2019 and Forecast 2020-2030

16.1. Introduction

16.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

16.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

16.3.1. By Country

16.3.1.1. Germany

16.3.1.2. Italy

16.3.1.3. France

16.3.1.4. U.K.

16.3.1.5. Spain

16.3.1.6. BENELUX

16.3.1.7. Russia

16.3.1.8. Rest of Europe

16.3.2. By Product Type

16.3.3. By Sample Type

16.3.4. By Technology

16.3.5. By End User

16.4. Market Attractiveness Analysis

16.5. Key Market Participants - Intensity Mapping

16.6. Drivers and Restraints - Impact Analysis

17. South Asia Market Analysis 2015-2019 and Forecast 2020-2030

17.1. Introduction

17.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

17.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

17.3.1. By Country

17.3.1.1. India

17.3.1.2. Thailand

17.3.1.3. Indonesia

17.3.1.4. Malaysia

17.3.1.5. Rest of South Asia

17.3.2. By Product Type

17.3.3. By Sample Type

17.3.4. By Technology

17.3.5. By End User

17.4. Market Attractiveness Analysis

17.5. Key Market Participants - Intensity Mapping

17.6. Drivers and Restraints - Impact Analysis

18. East Asia Market Analysis 2015-2019 and Forecast 2020-2030

18.1. Introduction

18.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

18.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

18.3.1. By Country

18.3.1.1. China

18.3.1.2. Japan

18.3.1.3. South Korea

18.3.2. By Product Type

18.3.3. By Sample Type

18.3.4. By Technology

18.3.5. By End User

18.4. Market Attractiveness Analysis

18.5. Key Market Participants - Intensity Mapping

18.6. Drivers and Restraints - Impact Analysis

19. Oceania Market Analysis 2015-2019 and Forecast 2020-2030

19.1. Introduction

19.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

19.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

19.3.1. By Country

19.3.1.1. Australia

19.3.1.2. New Zealand

19.3.2. By Product Type

19.3.3. By Sample Type

19.3.4. By Technology

19.3.5. By End User

19.4. Market Attractiveness Analysis

19.5. Key Market Participants - Intensity Mapping

19.6. Drivers and Restraints - Impact Analysis

20. Middle East and Africa Market Analysis 2015-2019 and Forecast 2020-2030

20.1. Introduction

20.2. Historical Market Size (US$ Mn) & Volume Analysis By Market Taxonomy, 2015-2019

20.3. Market Size (US$ Mn) & Volume Forecast By Market Taxonomy, 2020-2030

20.3.1. By Country

20.3.1.1. GCC Countries

20.3.1.2. Turkey

20.3.1.3. South Africa

20.3.1.4. Rest of Middle East and Africa

20.3.2. By Product Type

20.3.3. By Sample Type

20.3.4. By Technology

20.3.5. By End User

20.4. Market Attractiveness Analysis

20.5. Key Market Participants - Intensity Mapping

20.6. Drivers and Restraints - Impact Analysis

21. Key and Emerging Countries Market Analysis 2015-2019 and Forecast 2020-2030

21.1. Introduction

21.1.1. Market Value Proportion Analysis, By Key Countries

21.1.2. Global Vs. Country Growth Comparison

21.2. U.S. Market Analysis

21.2.1. By Product Type

21.2.2. By Sample Type

21.2.3. By Technology

21.2.4. By End User

21.3. Canada Market Analysis

21.3.1. By Product Type

21.3.2. By Sample Type

21.3.3. By Technology

21.3.4. By End User

21.4. Mexico Market Analysis

21.4.1. By Product Type

21.4.2. By Sample Type

21.4.3. By Technology

21.4.4. By End User

21.5. Brazil Market Analysis

21.5.1. By Product Type

21.5.2. By Sample Type

21.5.3. By Technology

21.5.4. By End User

21.6. U.K. Market Analysis

21.6.1. By Product Type

21.6.2. By Sample Type

21.6.3. By Technology

21.6.4. By End User

21.7. Germany Market Analysis

21.7.1. By Product Type

21.7.2. By Sample Type

21.7.3. By Technology

21.7.4. By End User

21.8. France Market Analysis

21.8.1. By Product Type

21.8.2. By Sample Type

21.8.3. By Technology

21.8.4. By End User

21.9. Italy Market Analysis

21.9.1. By Product Type

21.9.2. By Sample Type

21.9.3. By Technology

21.9.4. By End User

21.10. Spain Market Analysis

21.10.1. By Product Type

21.10.2. By Sample Type

21.10.3. By Technology

21.10.4. By End User

21.11. BENELUX Market Analysis

21.11.1. By Product Type

21.11.2. By Sample Type

21.11.3. By Technology

21.11.4. By End User

21.12. Russia Market Analysis

21.12.1. By Product Type

21.12.2. By Sample Type

21.12.3. By Technology

21.12.4. By End User

21.13. China Market Analysis

21.13.1. By Product Type

21.13.2. By Sample Type

21.13.3. By Technology

21.13.4. By End User

21.14. Japan Market Analysis

21.14.1. By Product Type

21.14.2. By Sample Type

21.14.3. By Technology

21.14.4. By End User

21.15. South Korea Market Analysis

21.15.1. By Product Type

21.15.2. By Sample Type

21.15.3. By Technology

21.15.4. By End User

21.16. India Market Analysis

21.16.1. By Product Type

21.16.2. By Sample Type

21.16.3. By Technology

21.16.4. By End User

21.17. ASEAN Market Analysis

21.17.1. By Product Type

21.17.2. By Sample Type

21.17.3. By Technology

21.17.4. By End User

21.18. Australia Market Analysis

21.18.1. By Product Type

21.18.2. By Sample Type

21.18.3. By Technology

21.18.4. By End User

21.19. New Zealand Market Analysis

21.19.1. By Product Type

21.19.2. By Sample Type

21.19.3. By Technology

21.19.4. By End User

21.20. GCC Countries Market Analysis

21.20.1. By Product Type

21.20.2. By Sample Type

21.20.3. By Technology

21.20.4. By End User

21.21. Turkey Market Analysis

21.21.1. By Product Type

21.21.2. By Sample Type

21.21.3. By Technology

21.21.4. By End User

21.22. South Africa Market Analysis

21.22.1. By Product Type

21.22.2. By Sample Type

21.22.3. By Technology

21.22.4. By End User

22. Market Structure Analysis

22.1. Market Analysis by Tier of Companies

22.2. Market Concentration

22.3. Market Share Analysis of Top Players

22.4. Market Presence Analysis

22.4.1. By Regional footprint of Players

22.4.2. Product foot print by Players

22.4.3. Channel Foot Print by Players

23. Competition Analysis

23.1. Competition Dashboard

23.2. Competition Benchmarking

23.3. Competition Deep Dive

23.3.1. Thermo Fisher Scientific, Inc.

23.3.1.1. Overview

23.3.1.2. Product Portfolio

23.3.1.3. Profitability by Market Segments (Product/Channel/Region)

23.3.1.4. Sales Footprint

23.3.1.5. Strategy Overview

23.3.1.5.1. Marketing Strategy

23.3.1.5.2. Product Strategy

23.3.1.5.3. Channel Strategy

23.3.2. Danaher

23.3.2.1. Overview

23.3.2.2. Product Portfolio

23.3.2.3. Profitability by Market Segments (Product/Channel/Region)

23.3.2.4. Sales Footprint

23.3.2.5. Strategy Overview

23.3.2.5.1. Marketing Strategy

23.3.2.5.2. Product Strategy

23.3.2.5.3. Channel Strategy

23.3.3. F. Hoffman-La Roche Ltd.

23.3.3.1. Overview

23.3.3.2. Product Portfolio

23.3.3.3. Profitability by Market Segments (Product/Channel/Region)

23.3.3.4. Sales Footprint

23.3.3.5. Strategy Overview

23.3.3.5.1. Marketing Strategy

23.3.3.5.2. Product Strategy

23.3.3.5.3. Channel Strategy

23.3.4. Hologic Inc.

23.3.4.1. Overview

23.3.4.2. Product Portfolio

23.3.4.3. Profitability by Market Segments (Product/Channel/Region)

23.3.4.4. Sales Footprint

23.3.4.5. Strategy Overview

23.3.4.5.1. Marketing Strategy

23.3.4.5.2. Product Strategy

23.3.4.5.3. Channel Strategy

23.3.5. Laboratory Corporation of America Holdings

23.3.5.1. Overview

23.3.5.2. Product Portfolio

23.3.5.3. Profitability by Market Segments (Product/Channel/Region)

23.3.5.4. Sales Footprint

23.3.5.5. Strategy Overview

23.3.5.5.1. Marketing Strategy

23.3.5.5.2. Product Strategy

23.3.5.5.3. Channel Strategy

23.3.6. Luminex Corporation

23.3.6.1. Overview

23.3.6.2. Product Portfolio

23.3.6.3. Profitability by Market Segments (Product/Channel/Region)

23.3.6.4. Sales Footprint

23.3.6.5. Strategy Overview

23.3.6.5.1. Marketing Strategy

23.3.6.5.2. Product Strategy

23.3.6.5.3. Channel Strategy

23.3.7. Mylab Discovery Solutions Pvt Ltd.

23.3.7.1. Overview

23.3.7.2. Product Portfolio

23.3.7.3. Profitability by Market Segments (Product/Channel/Region)

23.3.7.4. Sales Footprint

23.3.7.5. Strategy Overview

23.3.7.5.1. Marketing Strategy

23.3.7.5.2. Product Strategy

23.3.7.5.3. Channel Strategy

23.3.8. Neuberg Diagnostics

23.3.8.1. Overview

23.3.8.2. Product Portfolio

23.3.8.3. Profitability by Market Segments (Product/Channel/Region)

23.3.8.4. Sales Footprint

23.3.8.5. Strategy Overview

23.3.8.5.1. Marketing Strategy

23.3.8.5.2. Product Strategy

23.3.8.5.3. Channel Strategy

23.3.9. Perkin Elmer, Inc.

23.3.9.1. Overview

23.3.9.2. Product Portfolio

23.3.9.3. Profitability by Market Segments (Product/Channel/Region)

23.3.9.4. Sales Footprint

23.3.9.5. Strategy Overview

23.3.9.5.1. Marketing Strategy

23.3.9.5.2. Product Strategy

23.3.9.5.3. Channel Strategy

23.3.10. Quest Diagnostics

23.3.10.1. Overview

23.3.10.2. Product Portfolio

23.3.10.3. Profitability by Market Segments (Product/Channel/Region)

23.3.10.4. Sales Footprint

23.3.10.5. Strategy Overview

23.3.10.5.1. Marketing Strategy

23.3.10.5.2. Product Strategy

23.3.10.5.3. Channel Strategy

23.3.11. Quidel Corporation

23.3.11.1. Overview

23.3.11.2. Product Portfolio

23.3.11.3. Profitability by Market Segments (Product/Channel/Region)

23.3.11.4. Sales Footprint

23.3.11.5. Strategy Overview

23.3.11.5.1. Marketing Strategy

23.3.11.5.2. Product Strategy

23.3.11.5.3. Channel Strategy

23.3.12. Merck KGaA

23.3.12.1. Overview

23.3.12.2. Product Portfolio

23.3.12.3. Profitability by Market Segments (Product/Channel/Region)

23.3.12.4. Sales Footprint

23.3.12.5. Strategy Overview

23.3.12.5.1. Marketing Strategy

23.3.12.5.2. Product Strategy

23.3.12.5.3. Channel Strategy

23.3.13. Veredus Laboratories

23.3.13.1. Overview

23.3.13.2. Product Portfolio

23.3.13.3. Profitability by Market Segments (Product/Channel/Region)

23.3.13.4. Sales Footprint

23.3.13.5. Strategy Overview

23.3.13.5.1. Marketing Strategy

23.3.13.5.2. Product Strategy

23.3.13.5.3. Channel Strategy

23.3.14. Abbott Laboratories

23.3.14.1. Overview

23.3.14.2. Product Portfolio

23.3.14.3. Profitability by Market Segments (Product/Channel/Region)

23.3.14.4. Sales Footprint

23.3.14.5. Strategy Overview

23.3.14.5.1. Marketing Strategy

23.3.14.5.2. Product Strategy

23.3.14.5.3. Channel Strategy

24. Assumptions and Acronyms Used

25. Research Methodology